213 related articles for article (PubMed ID: 23567764)
1. [The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
Marullo AG; Iacò AL; Calafiore AM
G Ital Cardiol (Rome); 2013 Apr; 14(4):246-7. PubMed ID: 23567764
[No Abstract] [Full Text] [Related]
2. Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?
Efthymiou CA; Mills RJ; O'Regan DJ
J Card Surg; 2013 Nov; 28(6):723-9. PubMed ID: 23992398
[TBL] [Abstract][Full Text] [Related]
3. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
[TBL] [Abstract][Full Text] [Related]
5. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Colli A; Verhoye JP; Leguerrier A; Gherli T
Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
[TBL] [Abstract][Full Text] [Related]
7. New evidence on old drugs; warfarin versus aspirin after bioprosthetic aortic valve placement.
Stevens SM; Doty JR
Thromb Res; 2017 Feb; 150():102-103. PubMed ID: 28012566
[No Abstract] [Full Text] [Related]
8. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
9. Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
Bravata DM; Coffing JM; Kansagara D; Myers J; Murphy L; Homoya BJ; Perkins AJ; Snow K; Quin JA; Zhang Y; Myers LJ
JAMA Surg; 2019 Feb; 154(2):e184679. PubMed ID: 30586138
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy following bioprosthetic aortic valve replacement.
Nowell J; Wilton E; Markus H; Jahangiri M
Eur J Cardiothorac Surg; 2007 Apr; 31(4):578-85. PubMed ID: 17267235
[TBL] [Abstract][Full Text] [Related]
12. An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.
Vaughan P; Waterworth PD
J Heart Valve Dis; 2005 Sep; 14(5):576-82. PubMed ID: 16245494
[TBL] [Abstract][Full Text] [Related]
13. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
Al-Atassi T; Lam K; Forgie M; Boodhwani M; Rubens F; Hendry P; Masters R; Goldstein W; Bedard P; Mesana T; Ruel M
Circulation; 2012 Sep; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
[TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
15. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
16. Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?
Whitlock RP; Eikelboom JW
J Am Coll Cardiol; 2012 Sep; 60(11):978-80. PubMed ID: 22921974
[No Abstract] [Full Text] [Related]
17. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
18. Platelet inhibition by aspirin after aortic valve replacement.
Zimmermann N; Roussiekan T; Winter J; Kurt M; Gams E; Wenzel F; Hohlfeld T
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1392-3. PubMed ID: 16733175
[No Abstract] [Full Text] [Related]
19. Should we anticoagulate after bioprosthetic aortic valve replacement?
Al-Atassi T; Toeg H; Ruel M
Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1649-57. PubMed ID: 24215195
[TBL] [Abstract][Full Text] [Related]
20. [Thrombocytosis of mechanical prosthetic heart valves is al life-threatening condition. Thrombocyte inhibition possible as treatment and prevention].
Stenudd J; Linder R
Lakartidningen; 2011 May 4-10; 108(18):988-91. PubMed ID: 21809526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
